Meningitec meningococcal serogroup C conjugate vaccine suspension for injection, single dose syringe - update

Recall - potential for particulate contamination

2 December 2014

The TGA is aware that some health professionals may not have received information regarding a recall of all unexpired doses of Meningitec meningococcal serogroup C conjugate vaccine suspension for injection, single dose syringe from the product's sponsor, Emerge Health.

The recall was undertaken due to the potential for particulate contamination and the TGA published a related safety alert on 29 September 2014.

Health professionals who have any questions or would like further information about this issue can contact Emerge Health by phone on 03 9077 4486 or email at medicalaffairs@emergehealth.com.au.

If you are a consumer and have any questions or concerns about this issue, or any other issue involving vaccines, talk to your health professional.